Source: Frontiers in pharmacology. Unidade: FM
Subjects: DOENÇAS VASCULARES, ASMA, LIPOPOLISSACARÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMARGO, Leandro do Nascimento et al. Bronchial vascular remodeling is attenuated by anti-IL-17 in asthmatic responses exacerbated by LPS. Frontiers in pharmacology, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.01269. Acesso em: 10 out. 2024.APA
Camargo, L. do N., Santos, T. M. dos, Andrade, F. C. P. de, Fukuzaki, S., Lopes, F. D. T. Q. dos S., Martins, M. de A., et al. (2020). Bronchial vascular remodeling is attenuated by anti-IL-17 in asthmatic responses exacerbated by LPS. Frontiers in pharmacology, 11. doi:10.3389/fphar.2020.01269NLM
Camargo L do N, Santos TM dos, Andrade FCP de, Fukuzaki S, Lopes FDTQ dos S, Martins M de A, Prado CM, Leick EA, Righetti RF, Tiberio I de FLC. Bronchial vascular remodeling is attenuated by anti-IL-17 in asthmatic responses exacerbated by LPS [Internet]. Frontiers in pharmacology. 2020 ; 11[citado 2024 out. 10 ] Available from: https://doi.org/10.3389/fphar.2020.01269Vancouver
Camargo L do N, Santos TM dos, Andrade FCP de, Fukuzaki S, Lopes FDTQ dos S, Martins M de A, Prado CM, Leick EA, Righetti RF, Tiberio I de FLC. Bronchial vascular remodeling is attenuated by anti-IL-17 in asthmatic responses exacerbated by LPS [Internet]. Frontiers in pharmacology. 2020 ; 11[citado 2024 out. 10 ] Available from: https://doi.org/10.3389/fphar.2020.01269